Novartis: Business Week selects Visudyne therapy as one of the best products of 2000
Recognition further expands public awareness of new AMD treatment and educates public on devastating eye disease
15-Dec-2000 -
CIBA Vision, the eye care unit of Novartis AG (NYSE:NVS), and QLT Inc. (NASDAQ: QLTI; TSE: QLT) announced today that
Visudyne, their breakthrough medical treatment for the leading cause of blindness in people over the age of 50 in the Western world, has been selected by Business Week magazine ...
blindness
eye disease
food
+1